BioCentury
ARTICLE | Company News

Forest, Gruenenthal unveil pain deal

December 7, 2010 1:51 AM UTC

Gruenenthal Group (Aachen, Germany) granted Forest Laboratories Inc. (NYSE:FRX) exclusive rights in the U.S. and Canada to co-develop and commercialize two candidates for pain. GRT6005 and follow-on c...